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Background: To determine if the effects of epinephrine administration on the outcome of out-of-hospital cardiac
arrest (OHCA), patients are associated with the duration of cardiopulmonary resuscitation (CPR) performed by
Emergency Medical Service (EMS) personnel.
Methods: This retrospective, nonrandomized, observational analysis used the All-Japan Utstein Registry, a prospective,
nationwide population-based registry of all OHCA patients transported to the hospital by EMS staff as the data source.
We stratified all OHCA patients for quartile of EMSs’ CPR duration. Group 1 consisted of patients who fell under the
25th percentile of EMSs’ CPR duration (under 15 min); group 2, patients who fell into the 25th to 50th percentile
(between 15 and 19 min); group 3, patients who fell into the 50th to 75th percentile (between 20 and 26 min);
and group 4, patients who fell at or above the 75th percentile (over 26 min). The primary endpoint was a favorable
neurological outcome 1 month after cardiac arrest. The secondary endpoints were ROSC before arrival at the hospital
and 1-month survival.
Results: A total of 383,811 patients aged over 18 years who had experienced OHCA between 2006 and 2010 in
Japan, when stratified for quartile of EMSs’ CPR duration, the epinephrine administration increased the rate of return
of spontaneous circulation (ROSC) approximately tenfold in all groups. However, the beneficial effects of epinephrine
administration on 1-month survival disappeared in patients on whom EMSs’ CPR had been performed for more than
26 min, and the beneficial effects of epinephrine administration on neurological outcomes were observed only in
patients on whom EMSs’ CPR had been performed between 15 and 19 min (odds ratio, 1.327, 95 % confidence
intervals, 1.017–1.733 P = 0.037).
Conclusions: Epinephrine administration is associated with an increase of ROSC and with improvement in the
neurological outcome on which EMSs’ CPR duration is performed between 15 and 19 min.
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The administration of epinephrine for cardiopulmo-
nary resuscitation (CPR) has been advocated for de-
cades [1] and is recommended in both the 2010
International Consensus on Cardiopulmonary Resus-
citation and Emergency Cardiovascular Care Science
[2] and the 2010 American Heart Association Guidelines
for Cardiopulmonary Resuscitation and Emergency
Cardiovascular Care [3]. However, a large observational* Correspondence: rjtkk3299@yahoo.co.jp
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creativecommons.org/publicdomain/zero/1.0/before-and-after study in Singapore found that epi-
nephrine treatment is not beneficial for immediate or
1-month survival [4]. While, in contrast, several pre-
vious studies reported that epinephrine administra-
tion increases the frequency of return of spontaneous
circulation (ROSC) [5–8], they also raised doubts re-
garding the effects of epinephrine on the neurological
outcomes in patients with out-of-hospital cardiac arrest
(OHCA). Specifically, they indicated that although epi-
nephrine administration increases the short-term survival
rate in this patient population, it does not improve neuro-
logical outcomes [5–8].le distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
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permitted to administer epinephrine to patients with
OHCA. In a recent large prospective observational pro-
pensity analysis of epinephrine administration to OHCA
patients using the All-Japan Utstein database, Hagihara
et al. [9] concluded that prehospital epinephrine admin-
istration to patients with OHCA significantly increases
the likelihood of ROSC before hospital arrival but is not
associated with an increase in either survival or good
functional outcome 1 month after the event. Although
Hagihara et al. as well as other previous studies
failed to demonstrate the effectiveness of epinephrine
treatment in improving neurological outcomes in pa-
tients with OHCA, epinephrine administration during
CPR has long been, and remains, an internationally
accepted treatment.
In support of epinephrine treatment, we hypothesized
that the poor results observed in previous studies reflect
their lack of consideration of the duration of CPR per-
formed by EMS staff before the patient’s arrival at the
hospital. The interval is the period when specially
trained EMS personnel are able to administer epineph-
rine. Specifically, we hypothesized that a shorter dur-
ation of EMSs’ CPR would reduce the likelihood of
epinephrine administration and be more likely to result
in favorable outcomes, whereas a longer duration of
EMSs’ CPR would increase the likelihood of epinephrine
administration and be more likely to result in unfavor-
able outcomes. To test the hypothesis that the effects of
epinephrine administration on patient prognosis depend
on the duration of CPR performed by EMS personnel,
we evaluated the effect of the performance of EMSs’




This study was a retrospective analysis of prospectively
collected data contained in the All-Japan Utstein
Registry of OHCA patients. The registry was initiated
in January 2005 as a prospective nationwide population-
based registry of all OHCA patients transported to the
hospital by EMS staff and is managed by the Fire and
Disaster Management Agency (FDMA). As the public
has access to the data contained in the registry, the
Institutional Review Board of Hokkaido University
Hospital for Clinical Research waived the requirements to
obtain written informed consent from the patients in-
cluded in the database and to submit a study plan.
Japanese EMS system characteristics and procedures
The Japanese EMS system has been described previously
[10–12]. In most cases, the ambulance crew consists
of three emergency team members. One member isspecially trained in EMS, specifically the provision of
prehospital emergency care, and is permitted to insert
an intravenous line and advanced airway device (i.e.,
laryngeal mask airway, laryngeal tube, or esophageal-
tracheal twin-lumen airway) and use semiautomated ex-
ternal defibrillators. Although this specially trained EMS
team member is permitted to administer epinephrine
and insert an endotracheal tube with the approval of the
online emergency physician, in many regions of Japan,
he or she is not permitted to administer epinephrine to
OHCA patients with asystole as the primary electrocar-
diogram (ECG) rhythm and/or without a bystander act-
ing as a witness.
When cardiac arrest is diagnosed, chest compression
and ventilation using a bag-valve mask are immediately
initiated, and CPR is provided by the EMS personnel ac-
cording to international guidelines [3]. If necessary, the
EMS personnel insert an advanced airway device and
apply a semiautomated external defibrillator, after which
they attempt to gain peripheral venous access to admin-
ister 1 mg of epinephrine intravenously every 3 to 5 min
until the ROSC or arrival at the hospital. No drugs
other than epinephrine are permitted for use by EMS
personnel in Japan. After attempting defibrillation,
inserting an advanced airway device, and administer-
ing epinephrine, the EMS staff transfer the patient to
the hospital while performing CPR. If unable to gain
peripheral venous access at the scene, they again attempt
to gain peripheral venous access in the ambulance after
departing from the scene. Upon arrival at the hospital, the
patient is provided with advanced life support, including
the administration of epinephrine.
Patient selection
The patients in this study were selected from among all
patients who had experienced OHCA before the arrival
of EMS personnel and were subsequently treated by
EMS personnel and transported to a medical institution
in Japan between 1 January 2006 and 31 December
2010. We excluded patients under 18 years of age; in
whom spontaneous circulation had been restored before
the arrival of EMS personnel; for whom medical records
were missing data; whose condition had unlikely been
due to cardiac arrest; for whom more than 480 min had
elapsed from the emergency call to hospital arrival, more
than 60 min from the emergency call to the initiation of
CPR, or more than 120 min from the initiation of CPR to
hospital; who had been transferred with a physician rather
than with specially trained EMS personnel; and/or whose
OHCA episode had been witnessed by EMS personnel.
Patient grouping
The patients were divided into four groups based on
EMSs’ CPR duration, defined as the interval from the
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hospital. The interval is the period when specially
trained EMS personnel are able to administer epineph-
rine. Group 1 consisted of patients who fell under the
25th percentile of EMSs’ CPR duration (under 15 min);
group 2, patients who fell into the 25th to 50th percentile
(between 15 and 19 min); group 3, patients who fell into
in the 50th to 75th percentile (between 20 and 26 min);
and group 4, patients who fell at or above the 75th percent-
ile (over 26 min). To assess baseline patient characteristics,
the patients were further divided into the epinephrine
administration group and the non-epinephrine administra-
tion group.
Data collection
The duration of all procedures was recorded with the
timekeeping device used by each EMS system, which re-
corded receipt of the emergency call by the EMS, ambu-
lance arrival at the scene, initial contact with the patient,
initiation of CPR, and arrival at the hospital. The data
collected included patient sex and age, initial cardiac
rhythm, and time course of resuscitation, as well as
whether a bystander had witnessed the episode of car-
diac arrest and/or initiated CPR, the patient had been
intubated, epinephrine had been administered, or spon-
taneous circulation had been restored before arrival atFig. 1 Study participant selection. OHCA out-of-hospital cardiac arrest, EMSthe hospital. One month after the event, follow-up data
were collected regarding survival and neurologic status
by the EMS staff person in charge of the patient with
OHCA during a meeting with the medical control dir-
ector at the hospital. In partnership with the medical
control director, the emergency personnel summarized
the data for each OHCA case in standardized Utstein
style. Using these procedures, the data collected at ap-
proximately 800 fire stations maintaining dispatch cen-
ters in 47 prefectures were integrated into the national
registry system on the FDMA database server.
Outcome investigation
The primary endpoint was a favorable neurological out-
come 1 month after cardiac arrest. A favorable neuro-
logical outcome was defined as a cerebral performance
category score of 1 (good performance) or 2 (moderate
disability) and an unfavorable neurological outcome as a
score of 3 (severe cerebral disability), 4 (vegetative state),
or 5 (death) [13–16]. The secondary endpoints were ROSC
before arrival at the hospital and 1-month survival.
Statistical analysis
The patient characteristics and outcomes were com-
pared between two groups using Student’s t-test for nu-
merical variables and the chi-square test for categoricalemergency medical service
Table 1 Characteristics of patients with out-of-hospital cardiac
arrest according to epinephrine administration (n = 383,811)
Epinephrine No Epinephrine P value
(n = 29067) (n = 354744)
Age, mean (SD), years 73.24 (15.3) 73.35 (16.4) 0.275
Male sex 18271 (62.9) 203925 (57.5) <0.001
Bystander eyewitness 16081 (55.3) 121046 (34.1) <0.001
CPR initiated by bystander 13692 (47.1) 148974 (42.0) <0.001
Chest compression 13559 (46.9) 146701 (41.5) <0.001
Rescue breathing 3955 (13.7) 45330 (12.9) <0.001
Use of public-access AED 292 (1.0) 1690 (0.5) <0.001
Intrinsic origin of cardiac arrest
Cardiac 16652 (60.2) 183411 (53.9) <0.001
Non cardiac 6344 (23.0) 90971 (26.7)
Exogenous origin 4646 (16.8) 66004 (19.4)
Primary ECG rhythm
VF 3899 (13.4) 24064 (6.8) <0.001
Non VF 25168 (86.6) 330680 (93.2)
Life support by EMS personnel
Defibrillation 5797 (20.0) 33236 (9.4) <0.001
Advanced airway management 21866 (75.3) 160501 (45.3) <0.001
Time, mean (SD), min
Time from call to CPR initiation 9.37 (4.3) 9.11 (4.5) <0.001
Time from call to arrival at
the hospital
37.6 (11.9) 31.5 (11.4) <0.001
EMSs’ CPR duration 26.5 (10.1) 21.8 (9.9) <0.001
Outcome
ROSC 5088 (17.5) 14349 (4.0) <0.001
1-month survival 1448 (5.0) 13258 (3.7) <0.001
CPC 1 or 2 339 (1.2) 5430 (1.5) <0.001
Data are expressed as number (%), unless otherwise indicated
CPR cardiopulmonary resuscitation, AED automated external defibrillator,
VF ventricular fibrillation, EMS emergency medical service, ROSC return of
spontaneous circulation, CPC cerebral performance category
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fidence intervals (CIs) for outcomes were assessed by
performing logistic regression analysis that included the
variables of age, sex, bystander eyewitness, type(s) of
CPR techniques initiated by a bystander (chest compres-
sion, rescue breathing, and/or the use of a public-access
automated external defibrillator [AED]), cause of cardiac
arrest, primary ECG rhythm, type(s) of life support care
provided by EMS personnel (defibrillation, rescue
breathing, and/or advanced airway management), and
duration of all events. The SPSS 15.0J statistical software
package (SPSS Inc., Chicago, IL, USA) was used for all
statistical analyses. A P value of <0.05 was considered to
be statistically significant. Unless otherwise indicated, all
data are expressed as the mean (percentage).
Results
Patient selection
During the study period, 567,485 patients with OHCA
were transferred to a hospital by EMS personnel. Of
these patients, 82,939 for whom data were missing,
56,404 who had not experienced cardiac arrest or whose
spontaneous circulation had been restored upon EMS
personnel arrival, 8,472 who had been younger than 18
years, 130 for whom more than 480 min had elapsed
from the emergency call to hospital arrival, 1,255 for
whom more than 60 min had elapsed from the emer-
gency call to CPR initiation, 323 for whom more than
120 min had elapsed from CPR initiation to hospital ar-
rival, 12,956 who had been transferred with a physician,
and 21,195 who had not been transferred with specially
trained EMS personnel were excluded. After their exclu-
sion, the 383,811 remaining patients were included in
the analysis in the present study (Fig. 1).
Patient characteristics
Table 1 shows the characteristics of the two epinephrine
administration groups and Table 2 the characteristics
of the four EMSs’ CPR-duration groups. As can be
observed, the value of the first, second, and third
quartile of EMSs’ CPR duration was 15, 20, and 27 min,
respectively.
Patient outcomes
Table 3 shows the ORs for the outcomes of the four
EMSs’ CPR-duration groups adjusted for all the co-
variates listed in Table 1. In all groups, the epineph-
rine administration increased the rate of ROSC
approximately tenfold. However, the beneficial effects
of epinephrine administration on 1-month survival
disappeared in group 4, and the beneficial effects of
epinephrine administration on neurological outcomes
were observed only in group 2 (OR, 1.327, 95 % CI,
1.017–1.733 P = 0.037).Discussion
Analysis of the data contained in the All-Japan UT stein
registry database indicates that epinephrine administra-
tion to OHCA patients had improved the ROSC fre-
quency by nearly tenfold as well as the 1-month survival
of all patients except those on whom EMSs’ CPR had
been performed for more than 26 min (group 4) and the
neurological outcomes of patients on whom EMSs’ CPR
had been performed between 15 and 19 min (group 2).
The finding that epinephrine had not improved the
1-month survival of group 4 indicates that epineph-
rine administration may not be effective for patients
who undergo EMSs’ CPR of a relatively long duration.
The findings that resuscitation with epinephrine adminis-
tration yielded favorable neurological outcomes in only
group 2 indicate that epinephrine administration is
Table 2 Characteristics of patients according to the duration of EMSs’ CPR
Group Group 1 Group 2 Group 3 Group 4
<15 min 15–19 min 20–26 min ≥27 min
Characteristics Epinephrine No epinephrine P value Epinephrine No epinephrine P value Epinephrine No epinephrine P value Epinephrine No epinephrine P value
Cases 2766 90,681 5597 90,281 8179 85,490 12,525 88,292
Age, mean (SD), years 72.91 (15.1) 72.78 (16.7) 0.669 73.61 (14.9) 73.90 (16.2) 0.192 73.75 (15.4) 73.70 (16.2) 0.784 72.81 (15.4) 73.03 (16.3) 0.159
Male sex 1,673 (60.5) 52,377 (57.8) 0.004 3409 (60.9) 50,981 (56.5) <0.001 5103 (62.4) 48,810 (57.1) <0.001 8086 (64.6) 51,757 (58.6) <0.001
Bystander eyewitness 1,649 (59.6) 34,143 (37.7) <0.001 3032 (54.2) 29,389 (32.6) <0.001 4415 (54.0) 28,018 (32.8) <0.001 6985 (55.8) 29,496 (33.4) <0.001
CPR initiated by bystander
(non medically trained citizen)
1,407 (50.9) 39,423 (43.5) <0.001 2755 (49.2) 39,778 (44.1) <0.001 3897 (47.6) 35,778 (41.9) <0.001 5633 (45.0) 33,995 (38.5) <0.001
Chest compression 1391 (50.5) 38,763 (42.9) <0.001 2725 (49.0) 39,206 (43.6) <0.001 3863 (47.5) 35,251 (41.4) <0.001 5580 (44.8) 33,481 (38.0) <0.001
Rescue breathing 427 (15.5) 12,185 (13.5) 0.003 776 (14.0) 11,957 (13.3) 0.162 1112 (13.7) 10,725 (12.6) 0.005 1640 (13.2) 10,463 (11.9) <0.001
Use of public-access AED 31 (1.1) 632 (0.7) 0.012 58 (1.0) 375 (0.4) <0.001 82 (1.0) 333 (0.4) <0.001 121 (1.0) 350 (0.4) <0.001
Origin of cardiac arrest
Cardiac 1407 (54.3) 45,556 (52.9) 0.065 3110 (58.9) 46,811 (54.3) <0.001 4681 (60.4) 44,692 (54.4) <0.001 7454 (62.0) 46,352 (53.9) <0.001
Not cardiac 694 (26.8) 22,557 (26.2) 1216 (23.0) 22,906 (26.6) 1763 (22.8) 22,020 (26.8) 2671 (22.2) 23,488 (27.3)
Exogenous origin 492 (19.0) 17,958 (20.9) 954 (18.1) 16,538 (19.2) 1305 (16.8) 15,380 (18.7) 1895 (15.8) 16,128 (18.8)
Primary ECG rhythm
VF 467 (16.9) 9515 (10.5) <0.001 747 (13.3) 5223 (5.8) <0.001 1029 (12.6) 4743 (5.5) <0.001 1656 (13.2) 4583 (5.2) <0.001
non VF 2299 (83.1) 81,166 (89.5) 4850 (86.7) 85,058 (94.2) 7150 (87.4) 80,747 (94.5) 10,869 (86.8) 83,709 (94.8)
Life support by EMS personnel
Defibrillation 562 (20.3) 11,192 (12.4) <0.001 1011 (18.1) 7443 (8.3) <0.001 1494 (18.3) 7144 (8.4) <0.001 2730 (21.8) 7457 (8.5) <0.001
Advanced airway management 1822 (65.9) 26,738 (29.5) <0.001 3981 (71.2) 40,621 (45.0) <0.001 6258 (76.6) 44,293 (51.9) <0.001 9805 (78.4) 48,849 (55.4) <0.001
Time, mean (SD), min
Time from call to CPR initiation 8.63 (3.7) 8.45 (4.5) 0.034 8.58 (3.5) 8.70 (3.8) 0.02 8.99 (3.6) 9.14 (4.0) 0.001 10.13 (5.0) 10.20 (5.4) 0.188
Time from call to arrival at hospital 29.00 (10.8) 21.95 (7.1) <0.001 29.26 (7.4) 26.85 (4.4) <0.001 33.51 (5.8) 32.47 (4.6) <0.001 45.83 (11.5) 44.98 (11.5) <0.001
EMSs’ CPR duration 12.61 (2.3) 11.51 (3.3) <0.001 18.25 (1.3) 18.01 (1.4) <0.001 23.42 (1.7) 23.26 (1.7) <0.001 35.17 (9.0) 34.74 (9.3) <0.001
Outcome
ROSC 1561 (56.4) 11,860 (13.1) <0.001 1,413 (25.2) 1430 (1.6) <0.001 1211 (14.8) 665 (0.8) <0.001 903 (7.2) 394 (0.4) <0.001
1-month survival 503 (18.2) 8867 (9.8) <0.001 418 (7.5) 2181 (2.4) <0.001 297 (3.6) 1,284 (1.5) <0.001 230 (1.8) 926 (1.0) <0.001
CPC 1 or 2 136 (4.9) 4522 (5.0) 0.924 92 (1.6) 484 (0.5) <0.001 59 (0.7) 239 (0.3) <0.001 52 (0.4) 185 (0.2) <0.001
The data are expressed as number (%), unless otherwise indicated













Table 3 Adjusted odds ratios of epinephrine use for outcomes
in the four EMSs’ CPR-duration groups
Group Group 1 Group 2 Group 3 Group 4
<15 min 15–19 min 20–26 min ≥27 min
ROSC
OR 10.457 10.998 10.635 9.174
95 % CI 6.573–16.634 7.797–15.515 7.349–15.395 6.074–13.856
P value <0.001 <0.001 <0.001 <0.001
1-month survival
OR 1.425 1.538 1.386 1.124
95 % CI 1.254–1.619 1.347–1.755 1.200–1.602 0.959–1.318
P value <0.001 <0.001 <0.001 0.15
CPC 1 or 2
OR 0.967 1.327 0.967 1.03
95 % CI 0.774–1.027 1.017–1.733 0.774–1.207 0.728–1.458
P value 0.766 0.037 0.766 0.866
EMS emergency medical service, CPR cardiopulmonary resuscitation,
ROSC return of spontaneous circulation, OR odds ratio, CPC cerebral
performance category
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comes of only OHCA patients on whom EMSs’ CPR is
performed between 15 and 19 min. We consider in group
1 that epinephrine administration is effective like chest
compression and defibrillation et al., and in group 3
and 4, epinephrine administration would not be effective
because of long EMSs’ CPR duration.
Using the same database used in this study to conduct
propensity score matching, Hagihara et al. [9] found that
prehospital epinephrine administration to OHCA pa-
tients is significantly associated with an increased rate of
ROSC before hospital arrival but decreased rates of
survival and good neurological outcome 1 month after
the event. However, several controversial aspects of
Hagihara et al.’s study should be considered when asses-
sing their findings in relation to the findings of the
current study, foremost among which is the fact that
Hagihara et al. did not consider the duration of CPR. As
it is conceivable that the neurological outcomes of pa-
tients on whom EMSs’ CPR of long duration had been
performed are worse than those of patients on whom
EMSs’ CPR of short duration had been performed, the
former were more likely to have undergone epinephrine
administration by EMS staff and experience less favor-
able neurological outcome. Evidence of the significance
of EMSs’ CPR duration was obtained in the current
study, specifically the finding that the neurological out-
comes of patients in group 2 had been improved by
epinephrine administration. Another controversial as-
pect of Hagihara et al.’s study was its examination of
propensity variables that we argue should not have been
included in the analysis. One such variable was thepresence of specially trained EMS personnel in the am-
bulance despite the fact that EMS personnel who are not
specially trained are not permitted to administer epi-
nephrine in Japan. We therefore argue that the re-
searchers should have excluded patients who had been
treated by EMS personnel who had not been specially
trained. Another variable that we argue should not have
been included was the insertion of an intravenous line,
as EMS personnel are not permitted to administer epi-
nephrine without inserting a venous line. Furthermore
our study period was different from Hagihara et al.’s
study period; in April 2005, prehospital epinephrine
administration was introduced in Japan, so utilization in
the present study is higher than their study. This differ-
ence might affect the present findings.
Using the same database as that used by Hagihara
et al. to conduct time-dependent propensity score
matching, Nakahara et al. [17] recently found that pre-
hospital epinephrine administration by EMS personnel
improved 1-month survival but only minimally im-
proved the absolute increase in neurologically intact sur-
vival. However, as had Hagihara et al., they did not
consider the impact of EMSs’ CPR duration. Based on
the results of a recent randomized control trial that
compared the effects of epinephrine and a placebo in
OHCA patients, Jacobs et al. [18] and Olasveengen et al.
[8] reported that epinephrine administration increases
the frequency of ROSC in OHCA patients but does not
improve survival in the period prior to hospital dis-
charge. However, like the studies preceding them,
neither study considered EMSs’ CPR duration when
comparing the outcomes. In the present study, most of
the good neurological outcomes were experienced by pa-
tients in group 1 who had not been administered with
epinephrine (n = 4.522). If the OHCA patients had been
classified by EMSs’ CPR duration, the good neurological
outcome of patients in group 2 who had been adminis-
tered with epinephrine (n = 92) might have been sup-
pressed by the large number of good neurological
outcomes experienced by patients in group 1 who had
not been administered with epinephrine. Therefore, ran-
domized controlled trials by Jacobs et al. and Olasveen-
gen et al. might have failed to describe the effects of
prehospital epinephrine administration on OHCA.
The decreased favorable neurological outcomes as-
sociated with epinephrine use can be explained by
epinephrine-induced myocardial dysfunction [19, 20],
ventricular arrhythmia during the period after resus-
citation [21], or disturbed cerebral microcirculation
following cardiac arrest [22]. Another suspected factor is
provision of EMSs’ CPR of inadequate quality with epi-
nephrine administration, as the latter requires perform-
ance of procedures that are time consuming, such as
establishing intravenous access, and preparing and
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decrease focus on providing quality EMSs’ CPR [23–25].
Although Olasveengen et al. [8] reported that epinephrine
administration is not associated with poor quality EMSs’
CPR, the effects of epinephrine administration may be
minimal or nil [26] in patients who receive inadequate
EMSs’ CPR quality. Also, the present study showed that
prehospital epinephrine administration did not decrease
favorable neurological outcomes of all groups.
Although the results of the present study might pro-
vide evidence of an association between epinephrine ad-
ministration and favorable outcomes in OHCA patients,
they should be reviewed with consideration of the
study’s limitations. First, the quartile classification of
EMSs’ CPR duration might overestimate possible associ-
ation, inflate type 1 risk, and overestimate odds ratio.
Second, it was not possible to determine the timing of
epinephrine administration. Therefore, it was difficult to
determine whether the duration of EMSs’ CPR had been
determined prior to epinephrine administration, al-
though it is equally possible that absence of response to
epinephrine results in longer EMSs’ CPR duration and
that EMSs’ CPR duration is an outcome rather than a
predictor. Third, influence of time interval of cardiac
arrest is very important for neurological outcome, al-
though we cannot know this interval from the present
study for non-witness OHCA patients who were in-
cluded. Fourth, from the database we cannot know the
processes and the treatments after hospital admission.
Data regarding analysis of the effects of various pro-
cedures performed in the hospital, such as adminis-
tration of epinephrine or other vasopressor agents
(e.g., vasopressin), induction of hypothermia [27, 28],
and mechanical chest compression [29], were not
available. Nevertheless, it was possible that the patients
who had neither experienced ROSC nor been treated
with epinephrine may have been administered with epi-
nephrine by physicians after arriving at the hospital, as
well as that patients who had experienced ROSC and
been administered with epinephrine had received treat-
ment with induced hypothermia in the hospital. Fifth, the
neurological outcomes were assessed by each hospital in
a non-standardized manner, making comparison of the
outcomes at the different hospitals difficult. Finally the
cerebral performance category (CPC) scale used in the
study provides limited assessment of reliability and valid-
ity [30–32]. Sixth, epinephrine administration was discre-
tionally charged to personnel at the scene and region.
Consequently epinephrine was less frequently given in all
subgroup patients according to the duration of the EMSs’
CPR. This might produce bias by unidentified confound-
ing factors. Seventh, the present study enrolled OHCA
patients with non-cardiac cause or non-ventricular fibril-
lation (VF) rhythm. We expect that for these cases theresult might be different because epinephrine administra-
tion to these patients is not recognized as a standard.
Conclusions
The results of this study indicate that while epinephrine
administration is associated with an increase of the
survival of all OHCA patients, it is associated with im-
provement in the neurological outcomes of only OHCA
patients on whom EMSs’ CPR is performed between 15
and 19 min. Consideration of these findings leads us to
conclude that administration of epinephrine to OHCA
patients might be supported as a means of yielding fa-
vorable outcomes. As it is difficult to discuss the effect
of epinephrine administration on OHCA patients using
observational data, a large, randomized controlled trial
of epinephrine administration is now required.
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